Image

Global Pneumothorax Infection Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Pneumothorax Infection Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pneumothorax Infection Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 26.37 USD Billion
Diagram Market Size (Forecast Year) USD 47.24 USD Billion
Diagram CAGR %

Major Markets Players

  • Medtronic
  • Angiotech
  • Teleflex orporated
  • Abbott
  • Smiths Group plc

Global Pneumothorax Infection Treatment Market, By Type (Primary Spontaneous Pneumothorax, Secondary Spontaneous Pneumothorax, Latrogenic Pneumothorax, Injury-related Pneumothorax, Catamenial Pneumothorax), Treatment (Medication, Needle Aspiration, Chemical Pleurodesis, Chest Tube Drainage, Surgery, Others), Diagnosis (Chest X-ray, Computerized Tomography (CT) Scan, Ultrasound, Physical Examination, Others), Symptoms (Chest Pain, Tachypnoea, Dyspnoea, Dry cough, Subcutaneous emphysema, Signs of respiratory distress, Fatigue, Hypotension, Tachycardia, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Injectable, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

Pneumothorax Infection Treatment Market

Pneumothorax Infection Treatment Market Analysis and Size

The rise in the prevalence of pneumothorax infection and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, growing government funding and rising initiatives by public and private organisations to spread awareness about the disease and its available treatment are the factors that will expand the pneumothorax infection treatment market. Other factors including growing incidences of asthma, lung cancer, tuberculosis, cystic fibrosis and bacterial pneumonia and increase in the consumption of alcohol and smoking tobacco will positively impact the market growth rate.

Data Bridge Market Research analyses that the pneumothorax infection treatment market which was USD 19.18 billion in 2022, would rocket up to USD 53.35 billion by 2030, and is expected to undergo a CAGR of 5.30% during the forecast period. This indicates that the market value. “infectious diseases” dominates the application segment of the pneumothorax infection treatment market owing to an increase in the number of infectious diseases, such as COVID-19. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pneumothorax Infection Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Primary Spontaneous Pneumothorax, Secondary Spontaneous Pneumothorax, Latrogenic Pneumothorax, Injury-related Pneumothorax, Catamenial Pneumothorax), Treatment (Medication, Needle Aspiration, Chemical Pleurodesis, Chest Tube Drainage, Surgery, Others), Diagnosis (Chest X-ray, Computerized Tomography (CT) Scan, Ultrasound, Physical Examination, Others), Symptoms (Chest Pain, Tachypnoea, Dyspnoea, Dry cough, Subcutaneous emphysema, Signs of respiratory distress, Fatigue, Hypotension, Tachycardia, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Injectable, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Market Players Covered

Medtronic (Ireland), Angiotech (Canada), Teleflex Incorporated (U.S.), Abbott (U.S.), Smiths Group plc. (U.K.), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Nobelpharma Co., Ltd (Japan), Vygon (France), Zebra Medical Vision, Inc. (Israel), Allergan (Ireland), Merck Sharp & Dohme Corp. (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Eli Lilly and Company (U.S.),   among others

Market Opportunities

  • Launch of innovative and technologically advanced products to meet the needs of customers
  • Increase in the prevalence of infectious diseases
  • Increase in the number of mergers and acquisitions among manufacturers

Market Definition

Pneumothorax is also known as collapsed lung. When air gets into the space around your lungs, it's called a pneumothorax (the pleural space). When your chest wall is injured or your lung tissue is torn or ruptured, air can enter the pleural space, upsetting the pressure that keeps your lungs inflated. Lung disease, assisted breathing with a ventilator, injury from a sport or accident, or even variations in air pressure experienced during scuba diving or mountain climbing are all possible causes of ruptured or wounded chest or lung walls. The aetiology of a pneumothorax is sometimes unknown. This condition is characterized by chest pain, tachypnoea, dyspnoea, dry cough, and subcutaneous emphysema, signs of respiratory distress, fatigue, hypotension and tachycardia

Pneumothorax Infection Treatment Market Dynamics

Drivers

  • Increasing Incidence of Pneumothorax

The rising incidence of pneumothorax, which can result from various factors such as trauma, surgery, or underlying lung conditions, is a significant driver. As the population grows and ages, the prevalence of conditions leading to pneumothorax is likely to increase, driving the demand for pneumothorax infection treatment

  • Advancements in Medical Technology

Advances in medical technology, particularly in minimally invasive surgical techniques and imaging technologies, have improved the diagnosis and treatment of pneumothorax and related infections. These advancements make treatments more effective, less invasive, and reduce recovery times, thus boosting the market

  • Increasing Awareness and Early Diagnosis  

As awareness about the risks and consequences of pneumothorax and related infections grows, there is a greater emphasis on early diagnosis and treatment. Public health campaigns, medical education, and the integration of healthcare systems contribute to this awareness, driving market growth

  • Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities

Opportunities

  • Rising Healthcare Investments

Increasing investments in healthcare infrastructure, particularly in emerging markets, create opportunities for market growth. Expanding healthcare facilities, improving access to medical services, and enhancing the availability of advanced treatments can drive demand for pneumothorax infection treatment

  • Telemedicine and Remote Monitoring

The adoption of telemedicine and remote monitoring technologies offers opportunities to provide timely consultations and follow-up care for patients with pneumothorax and related infections. This can improve patient compliance with treatment plans and facilitate early intervention when necessary

Restraints/ Challenges

  • Limited Awareness and Diagnosis

Despite efforts to raise awareness, pneumothorax and related infections can still go undiagnosed or misdiagnosed. This limitation in early diagnosis and awareness can restrain market growth as delayed treatment may result in more severe cases

  • Stringent Regulatory Requirements

The development and approval of new treatments and medical devices for pneumothorax and associated infections are subject to stringent regulatory requirements. Complying with these regulations can be time-consuming and expensive, which can slow down the introduction of new products into the market

  • Diagnostic Challenges

Accurately diagnosing pneumothorax and associated infections can be challenging, especially in cases where symptoms are subtle or when imaging techniques are not readily available. Misdiagnosis or delayed diagnosis can lead to inadequate or delayed treatment

  • Treatment Complexity

The treatment of pneumothorax and related infections can be complex, especially in severe cases. Surgical interventions may be required, and these procedures can carry risks and complications. Balancing the need for effective treatment with the potential for adverse events can be a challenge

This pneumothorax infection treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pneumothorax infection treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Global Pneumothorax Infection Treatment Market Scope

The pneumothorax infection treatment market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Primary spontaneous pneumothorax
  • Secondary spontaneous pneumothorax
  • Latrogenic pneumothorax
  • Injury-related pneumothorax
  • Catamenial pneumothorax

Treatment

  • Medication
  • Antibiotics
  • Benzodiazepines
  • Opiate anesthetics
  • Others
  • Needle aspiration
  • Chemical pleurodesis
  • Chest tube drainage
  • Surgery
  • Others

Diagnosis

  • Chest x-ray
  • Computerized tomography (ct) scan
  • Ultrasound
  • Physical examination
  • Others

Symptoms

  • Chest pain
  • Tachypnea
  • Dyspnea
  • Dry cough
  • Subcutaneous emphysema
  • Signs of respiratory distress
  • Fatigue
  • Hypotension
  • Tachycardia
  • Others

Dosage

  • Tablet
  • Injection
  • Others

Route of Administration

  • Oral
  • Injectable
  • Others

End-users

  • Clinic
  • Hospital
  • Others

Distribution channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

Pneumothorax Infection Treatment Market Regional Analysis/Insights

The pneumothorax infection treatment market is analysed and market size insights and trends are provided by type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the pneumothorax infection treatment market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

North America dominates the pneumothorax infection treatment market due to presence of major key players, high disposable income and well-developed healthcare infrastructure in this region.   

Asia-Pacific is expected to grow during the forecast period of 2023 to 2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The pneumothorax infection treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pneumothorax infection treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pneumothorax infection treatment market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Pneumothorax Infection Treatment Market Share Analysis

The pneumothorax infection treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pneumothorax infection treatment market

Some of the major players operating in the pneumothorax infection treatment market are:

  • Medtronic (Ireland)
  • Angiotech (Canada)
  • Teleflex Incorporated (U.S.)
  • Abbott (U.S.)
  • Smiths Group plc. (U.K.)
  • ATMOS MedizinTechnik GmbH & Co. KG (Germany)
  • Nobelpharma Co., Ltd (Japan)
  • Vygon (France)
  • Zebra Medical Vision, Inc. (Israel)
  • Allergan (Ireland)
  • Merck Sharp & Dohme Corp. (U.S.)
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Eli Lilly and Company (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The pneumothorax infection treatment market size will be worth USD 53.35 billion by 2030.
The growth rate of the pneumothorax infection treatment market is 5.30% in the forecast by 2030.
Type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel are the factors on which the pneumothorax infection treatment market research is based.
Increasing incidence of pneumothorax, advancements in medical technology & increasing awareness and early diagnosis are the growth drivers of the pneumothorax infection treatment market.
Major companies in the pneumothorax infection treatment market are Medtronic (Ireland), Angiotech (Canada), Teleflex Incorporated (U.S.), Abbott (U.S.), Smiths Group plc. (U.K.), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Nobelpharma Co., Ltd (Japan), Vygon (France), Zebra Medical Vision, Inc. (Israel), Allergan (Ireland), Merck Sharp & Dohme Corp. (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Eli Lilly and Company (U.S.), among others.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials